FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion

被引:116
|
作者
Benlimame, N
He, Q
Jie, S
Xiao, DZ
Xu, YJ
Loignon, M
Schlaepfer, DD
Alaoui-Jamali, MA [1 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ H3T 1E2, Canada
[3] Scripps Res Inst, La Jolla, CA 92037 USA
来源
JOURNAL OF CELL BIOLOGY | 2005年 / 171卷 / 03期
关键词
D O I
10.1083/jcb.200504124
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The overexpression of members of the ErbB tyrosine kinase receptor family has been associated with cancer progression. We demonstrate that focal adhesion kinase (FAK) is essential for oncogenic transformation and cell invasion that is induced by ErbB-2 and -3 receptor signaling. ErbB-2/3 overexpression in FAK-deficient cells fails to promote cell transformation and rescue chemotaxis deficiency. Restoration of FAK rescues both oncogenic transformation and invasion that is induced by ErbB-2/3 in vitro and in vivo. In contrast, the inhibition of FAK in FAK-proficient invasive cancer cells prevented cell invasion and metastasis formation. The activation of ErbB-2/3 regulates FAK phosphorylation at Tyr-397, -861, and -925. ErbB-induced oncogenic transformation correlates with the ability of FAK to restore ErbB-2/3-induced mitogen-activated protein kinase ( MAPK) activation; the inhibition of MAPK prevented oncogenic transformation. In contrast, the inhibition of Src but not MAPK prevented ErbB-FAK-induced chemotaxis. In migratory cells, activated ErbB-2/3 receptors colocalize with activated FAK at cell protrusions. This colocalization requires intact FAK. In summary, distinct FAK signaling has an essential function in ErbB-induced oncogenesis and invasiveness.
引用
收藏
页码:505 / 516
页数:12
相关论文
共 50 条
  • [41] An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling
    Sala, G.
    Traini, S.
    D'Egidio, M.
    Vianale, G.
    Rossi, C.
    Piccolo, E.
    Lattanzio, R.
    Piantelli, M.
    Tinari, N.
    Natali, P. G.
    Muraro, R.
    Iacobelli, S.
    ONCOGENE, 2012, 31 (10) : 1275 - 1286
  • [42] Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa
    Kataoka, H
    Joh, T
    Kasugai, K
    Okayama, N
    Moriyama, A
    Asai, K
    Kato, T
    LIFE SCIENCES, 1998, 63 (07) : 553 - 564
  • [43] Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms
    Brys, M
    Stawinska, M
    Foksinski, M
    Barecki, A
    Zydek, C
    Miekos, E
    Krajewska, WM
    ONCOLOGY REPORTS, 2004, 11 (01) : 219 - 224
  • [44] An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling
    G Sala
    S Traini
    M D'Egidio
    G Vianale
    C Rossi
    E Piccolo
    R Lattanzio
    M Piantelli
    N Tinari
    P G Natali
    R Muraro
    S Iacobelli
    Oncogene, 2012, 31 : 1275 - 1286
  • [45] ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner
    Olayioye, MA
    Graus-Porta, D
    Beerli, RR
    Rohrer, J
    Gay, B
    Hynes, NE
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) : 5042 - 5051
  • [46] miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer
    Epis, Michael R.
    Giles, Keith M.
    Barker, Andrew
    Kendrick, Tulene S.
    Leedman, Peter J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (37) : 24696 - 24704
  • [47] Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer
    Muller, WJ
    Ho, J
    Siegel, PM
    MAMMARY DEVELOPMENT IN CANCER, 1998, (63): : 149 - 157
  • [48] COOPERATIVE SIGNALING OF ERBB3 AND ERBB2 IN NEOPLASTIC TRANSFORMATION AND HUMAN MAMMARY CARCINOMAS
    ALIMANDI, M
    ROMANO, A
    CURIA, MC
    MURARO, R
    FEDI, P
    AARONSON, SA
    DIFIORE, PP
    KRAUS, MH
    ONCOGENE, 1995, 10 (09) : 1813 - 1821
  • [49] Heregulins and the ErbB-2/3/4 receptors in gliomas
    Manfred Westphal
    Leonie Meima
    Eva Szonyi
    Julie Lofgren
    Hildegard Meissner
    Wolfgang Hamel
    Karoly Nikolics
    and Mark X. Sliwkowski
    Journal of Neuro-Oncology, 1997, 35 : 335 - 346
  • [50] Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer
    Rizzo, Paola
    Osipo, Clodia
    Pannuti, Antonio
    Golde, Todd
    Osborne, Barbara
    Miele, Lucio
    ADVANCES IN ENZYME REGULATION, VOL 49, 2009, 49 : 134 - 141